MedTrace Logo

Evaluation of Slit2 in Systemic Lupus Erythematosus and Systemic Sclerosis Patients

NCT05105217 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 85

Last updated 2021-11-03

No results posted yet for this study

Summary

1.Assessment of slit2 level in SLE patients and its correlation with disease activity.

2-Assessment of slit2 level in SSC patients and its correlation with disease activity

Conditions

Interventions

OTHER

Slit2 biomarker

1.Assessment of slit2 level in SLE patients and its correlation with disease activity. 2-Assessment of slit2 level in SSC patients and its correlation with disease activity

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
16 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-01
Primary Completion
2022-12-01
Completion
2023-02-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05105217 on ClinicalTrials.gov